
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

Source: https://gizmodo.com/fda-approves-breakthough-drug-to-prevent-hiv-2000617633
Disclaimer of liability !!!
NEWS.SP1.RO is an automatic news aggregator. In each article, taken over by NEWS.SP1.RO with maximum 500 characters from the original article, the source name and hyperlink to the source are specified.
The acquisition of information aims to promote and facilitate access to information, in compliance with intellectual property rights, in accordance with the terms and conditions of the source.
If you are the owner of the content and do not wish to publish your materials, please contact us by email at [email protected] and the content will be deleted as soon as possible.